Ritesh Thakare
Skin T-Cell Lymphoma (STCL), a rare form of non-Hodgkin lymphoma, presents a complex challenge in oncology due to its heterogeneity and resistance to conventional treatments. However, recent advancements in genomic research have shed light on promising genetic markers that could revolutionize the management of STCL. This article delves into the significance of these genetic markers in STCL treatment, exploring their implications for personalized medicine and the future of oncology.
Поделиться этой статьей
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi 